Rindopepimut vaccine and bevacizumab combination therapy: improving survival rates in relapsed glioblastoma patients?

Neagu, Martha R

Rindopepimut vaccine and bevacizumab combination therapy: improving survival rates in relapsed glioblastoma patients? [electronic resource] - Immunotherapy 2015 - 603-6 p. digital

Publication Type: Journal Article; Review

1750-7448

10.2217/imt.15.39 doi


Bevacizumab--therapeutic use
Cancer Vaccines--therapeutic use
Glioblastoma--therapy
Humans
Portraits as Topic
Recurrence
Vaccines, Subunit--therapeutic use